Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 31, 2025 • 5:01 PM ET

Date/Time Source News Release
03/19/2025 09:14 AM EDT GlobeNewswire Revive Therapeutics Announces Results of Annual Shareholder Meeting
03/03/2025 08:00 AM EST GlobeNewswire Revive Therapeutics Announces LOI to Acquire DiagnaMed's Molecular Hydrogen Program
02/03/2025 05:00 PM EST GlobeNewswire Revive Therapeutics Announces Update on R&D Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
01/08/2025 07:30 AM EST GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
11/12/2024 07:45 AM EST GlobeNewswire Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke
10/31/2024 07:30 AM EDT GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
09/18/2024 07:00 AM EDT GlobeNewswire Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures
08/28/2024 07:00 AM EDT GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure and Expansion into Viral Infections
07/02/2024 01:58 PM EDT GlobeNewswire Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
06/12/2024 09:05 AM EDT GlobeNewswire Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
Page

Additional News

As of March 31, 2025 • 5:01 PM ET

Date/Time Source News Release
02/26/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, February 26th, 2025
02/26/2025 04:31 AM EST US Earnings Reports Expected earnings - Revive Therapeutics Ltd
12/04/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, December 4th, 2024
12/04/2024 04:31 AM EST US Earnings Reports Expected earnings - Revive Therapeutics Ltd
11/06/2024 01:55 AM EST SeekingAlpha Massachusetts psychedelics legalization initiative poised to fail
11/04/2024 05:27 AM EST SeekingAlpha Legalizing psychedelics: Is Massachusetts next?
10/19/2024 09:40 AM EDT SeekingAlpha FDA is said to see "path forward" for ecstasy-based drug
10/16/2024 01:55 PM EDT SeekingAlpha Bright Minds rally ends as psychedelic stocks extend volatility
09/18/2024 07:09 AM EDT SeekingAlpha Revive Therapeutics to focus on Bucillamine
06/05/2024 07:17 AM EDT SeekingAlpha Psychedelic stocks fall as FDA panel rejects MDMA therapy
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.